Coronavirus-19: Clinical Trials

3 trials for Coronavirus-19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Withdrawn 1

Follow Coronavirus-19: new trials by email Literature Review of Coronavirus-19 trials Research Report on Coronavirus-19

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Combination Therapies to Treat COVID-19 Infection
hydroxychloroquine, Azithromycin, Ritonavir - COVID, COVID-19
Phase 2WithdrawnProgenaBiome2020-07-012021-04-08
A Study of Quintuple Therapy to Treat COVID-19 Infection
Hydroxychloroquine, Azithromycin, Vitamin C - COVID-19, Corona Virus Infection
Phase 2CompletedProgenaBiome1182020-06-222024-02-29
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
Hydroxychloroquine, Vitamin C, Vitamin D - COVID-19, Coronavirus Infection
Phase 2CompletedProgenaBiome2542020-06-222026-11-04

Narrower conditions

COVID-19 (3)  ·  Coronavirus Infections (3)

Broader conditions

Coronaviridae Infections (3)  ·  Infections (3)  ·  Lung Diseases (3)  ·  Nidovirales Infections (3)  ·  Pneumonia (3)  ·  Pneumonia, Viral (3)  ·  RNA Virus Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Virus Diseases (3)

Interventions

Hydroxychloroquine (3)  ·  Ascorbic Acid (2)  ·  Azithromycin (2)  ·  Vitamin D (2)  ·  Zinc (2)  ·  Lopinavir (1)  ·  Ritonavir (1)

Sponsors

ProgenaBiome (3)

Countries

United States (3)

Top investigators

Sabine Hazan, MD (3)  ·  Thomas Borody, MD, PhD, (1)